Clinical Trials Logo
  1. Home
  2. Colorectal Neoplasms
  3. NCT00051688
  4. Details
NCT00051688 Clinical Trial

Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer

Colorectal Neoplasms Clinical Trial

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT00051688
Other study ID # TEZ101
Secondary ID
Status Terminated
Phase Phase 2
First received January 15, 2003
Last updated July 10, 2006
Start date June 2003
Est. completion date August 2004

Study information
Verified date July 2006
Source Chiron Corporation
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The primary purpose of this study is to determine the best dose of tezacitabine when combined with oxaliplatin in patients with metastatic colorectal cancer. This study will also evaluate tumor response to the combination of anti-cancer drugs.

Recruitment information / eligibility
Status Terminated
Enrollment 0
Est. completion date August 2004
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility - Patients with metastatic colorectal adenocarcinoma who have failed one prior course of chemotherapy.

- Patients must have at least one measurable tumor.

- Patients may not have received prior treatment with oxaliplatin.

Study Design

Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• tezacitabine

• oxaliplatin

Locations
Country Name City State
United States Northwestern University Feinberg School of Medicine Chicago Illinois
United States Kansas City Oncology and Hematology Group Kansas City Missouri
United States USC/Norris Comprehensive Cancer Center Los Angeles California
United States Comprehensive Cancer Centers of the Desert Palm Springs California
United States Cancer Institute Medical Group Santa Monica California
United States H. Lee Moffitt Cancer Center & Research Institute Tampa Florida
United States ACRC/Arizona Clinical Research Center Tucson Arizona
United States Georgetown University Medical Center, Lombardi Cancer Center Washington District of Columbia

Sponsors (1)
Lead Sponsor Collaborator
Chiron Corporation

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Recruiting NCT04552093 - Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT) Phase 2/Phase 3
Completed NCT04192565 - A Prospective Investigation of the ColubrisMX ELS System N/A
Completed NCT05178745 - A Prospective Observational Cohort Study Evaluating Resection Rate in Patients With Metastatic Colorectal Cancer Treated With Aflibercept in Combination With FOLFIRI - Observatoire résection
Recruiting NCT03561350 - Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing
Recruiting NCT06128798 - Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery. N/A
Recruiting NCT03602677 - Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage N/A
Completed NCT03631407 - Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046) Phase 2
Withdrawn NCT04192929 - Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy N/A
Recruiting NCT03042091 - Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery Early Phase 1
Completed NCT02889679 - Underwater Resection of Non-pedunculated Colorectal Lesions N/A
Terminated NCT02842580 - De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer Phase 2
Completed NCT02564835 - Effects of Yoga on Cognitive and Immune Function in Colorectal Cancer N/A
Completed NCT02503696 - Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) N/A
Completed NCT02149108 - Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1) Phase 3
Completed NCT02599103 - The Effects of Various Cooking Oils on Health Related Biomarkers in Healthy Subjects N/A
Completed NCT01669109 - Hatha Yoga for Patients With Colorectal Cancer N/A
Completed NCT01719926 - Phase I Platinum Based Chemotherapy Plus Indomethacin Phase 1
Recruiting NCT01428752 - Study of Prevalence of Colorectal Adenoma in 30- to 49-year-old Subjects With a Family History of Colorectal Cancer N/A
Completed NCT01978717 - General Anesthesia Combined With Epidural Anesthesia Mitigates the Surgical Stress-related Immunosuppression in Patients With Colorectal Cancer N/A
Completed NCT01877018 - Colorectal Cancer Screening in Primary Care N/A